P. Kellie Turner

Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation

Stephen J. Nicholls, Steven E. Nissen, Cynthia Griggs Fleming et al. · JAMA · 2023 · 161 citations · Full text

Abemaciclib Inhibits Renal Tubular Secretion Without Changing Glomerular Filtration Rate

Jill C. Chappell, P. Kellie Turner, Y. Anne Pak et al. · Clinical Pharmacology & Therapeutics · 2018 · 110 citations · Full text

A Population Pharmacokinetic and Pharmacodynamic Analysis of Abemaciclib in a Phase I Clinical Trial in Cancer Patients

Sonya C. Tate, Amanda K. Sykes, Palaniappan Kulanthaivel et al. · Clinical Pharmacokinetics · 2017 · 68 citations · Full text

A First-in-Human Phase I Study of a Bivalent MET Antibody, Emibetuzumab (LY2875358), as Monotherapy and in Combination with Erlotinib in Advanced Cancer

Lee S. Rosen, Jonathan W. Goldman, Alain P. Algazi et al. · Clinical Cancer Research · 2016 · 67 citations

Phase 1 study of abemaciclib, an inhibitor of CDK 4 and 6, as a single agent for Japanese patients with advanced cancer

Yutaka Fujiwara, Kenji Tamura, Shunsuke Kondo et al. · Cancer Chemotherapy and Pharmacology · 2016 · 61 citations

Oncology, Single Agent, Medicine +8